NicVAX/Placebo as an Aid for Smoking Cessation

Completed · Phase 3 · Has a placebo group

Conditions studied: Smoking Cessation, Smoking, Tobacco Cessation

In brief

The purpose of this study is to evaluate NicVAX as an aid to smoking cessation for long term abstinence.

Key facts

Study ID

NCT00836199

Run by

Nabi Biopharmaceuticals

People needed

1000

Starts

2009-10-01

Expected to finish

2011-07-01

Last updated by the study team

2012-05-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current smoker who smokes at least 10 cigarettes a day during the past year and wants to quit smoking.
• Smokers who are in good general health.

You may not qualify if…

• Prior exposure to NicVAX or any other nicotine vaccine.
• Use of systemic steroids.
• Cancer or cancer treatment in last 5 years.
• HIV infection.
• History of drug or alcohol abuse or dependence within 12 months.
• Significant cardiovascular, hepatic, renal, psychiatric and/or respiratory disease.
• Inability to fulfill all visits for approximately 52 weeks.

Where it is running

• NicVAX Investigator — Tucson, Arizona, United States
• NicVAX Investigator — Los Angeles, California, United States
• NicVAX Investigator — Newport Beach, California, United States
• NicVAX Investigator — San Diego, California, United States
• NicVAX Investigator — Denver, Colorado, United States
• NicVAX Investigator — Farmington, Connecticut, United States
• NicVAX Investigator — Miami, Florida, United States
• NicVAX Investigator — St. Petersburg, Florida, United States
• NicVAX Investigator — Boise, Idaho, United States
• NicVAX Investigator — Lexington, Kentucky, United States
• NicVAX Investigator — Baltimore, Maryland, United States
• NicVAX Investigator — College Park, Maryland, United States
• NicVAX Investigator — Boston, Massachusetts, United States
• NicVAX Investigator — Minneapolis, Minnesota, United States
• NicVAX Investigator — Omaha, Nebraska, United States
• NicVAX Investigator — Rochester, New York, United States
• NicVAX Investigator — Raleigh, North Carolina, United States
• NicVAX Investigator — Portland, Oregon, United States
• NicVAX Investigator — Draper, Utah, United States
• NicVAX Investigator — Norfolk, Virginia, United States
• NicVAX Investigator — Seattle, Washington, United States
• NicVAX Investigator — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.